Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea
· Delayed Price · Currency is KRW 500,000
+18,500 (3.84%)
Mar 10, 2026, 12:00 PM KST
Hanmi Pharm. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 6,105,523 | 3,556,800 | 4,473,421 | 3,711,167 | 3,373,870 | 4,397,245 | Upgrade
|
| Market Cap Growth | 82.73% | -20.49% | 20.54% | 10.00% | -23.27% | 25.97% | Upgrade
|
| Enterprise Value | 6,477,527 | 4,027,046 | 4,935,354 | 4,226,778 | 4,030,879 | 5,216,052 | Upgrade
|
| Last Close Price | 481500.00 | 280500.00 | 350901.20 | 290409.65 | 263266.61 | 342142.63 | Upgrade
|
| PE Ratio | 52.41 | 29.32 | 30.59 | 44.83 | 50.34 | 367.69 | Upgrade
|
| Forward PE | 33.77 | 19.54 | 30.57 | 38.01 | 44.63 | 95.75 | Upgrade
|
| PS Ratio | 4.16 | 2.38 | 3.00 | 2.79 | 2.80 | 4.09 | Upgrade
|
| PB Ratio | 4.54 | 2.87 | 4.07 | 3.68 | 3.64 | 5.29 | Upgrade
|
| P/TBV Ratio | 5.36 | 3.42 | 4.92 | 4.51 | 4.47 | 6.44 | Upgrade
|
| P/FCF Ratio | 47.74 | 23.06 | 23.65 | 28.14 | 18.54 | 40.08 | Upgrade
|
| P/OCF Ratio | 35.23 | 18.38 | 20.66 | 22.87 | 16.71 | 29.02 | Upgrade
|
| PEG Ratio | 1.54 | 5.03 | 5.03 | 5.03 | 5.03 | 5.03 | Upgrade
|
| EV/Sales Ratio | 4.42 | 2.69 | 3.31 | 3.17 | 3.35 | 4.85 | Upgrade
|
| EV/EBITDA Ratio | 22.04 | 13.00 | 15.26 | 16.86 | 18.79 | 47.28 | Upgrade
|
| EV/EBIT Ratio | 33.07 | 18.95 | 21.95 | 27.47 | 32.14 | 106.50 | Upgrade
|
| EV/FCF Ratio | 50.65 | 26.11 | 26.09 | 32.05 | 22.15 | 47.54 | Upgrade
|
| Debt / Equity Ratio | 0.32 | 0.40 | 0.52 | 0.67 | 0.82 | 0.96 | Upgrade
|
| Debt / EBITDA Ratio | 1.48 | 1.60 | 1.77 | 2.71 | 3.53 | 7.27 | Upgrade
|
| Debt / FCF Ratio | 3.41 | 3.22 | 3.03 | 5.14 | 4.16 | 7.31 | Upgrade
|
| Net Debt / Equity Ratio | 0.16 | 0.25 | 0.29 | 0.44 | 0.59 | 0.79 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.72 | 0.98 | 0.98 | 1.76 | 2.54 | 5.93 | Upgrade
|
| Net Debt / FCF Ratio | 1.65 | 1.97 | 1.68 | 3.35 | 2.99 | 5.96 | Upgrade
|
| Asset Turnover | 0.73 | 0.76 | 0.78 | 0.69 | 0.63 | 0.57 | Upgrade
|
| Inventory Turnover | 2.15 | 2.30 | 2.38 | 2.37 | 2.04 | 1.56 | Upgrade
|
| Quick Ratio | 0.82 | 0.63 | 0.61 | 0.62 | 0.67 | 0.56 | Upgrade
|
| Current Ratio | 1.40 | 1.09 | 1.04 | 1.03 | 1.08 | 1.15 | Upgrade
|
| Return on Equity (ROE) | 9.90% | 12.00% | 15.68% | 10.48% | 9.26% | 2.09% | Upgrade
|
| Return on Assets (ROA) | 6.10% | 6.78% | 7.35% | 4.98% | 4.11% | 1.61% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.36% | 11.77% | 13.37% | 8.83% | 6.66% | 2.51% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.50% | 15.90% | 18.80% | 12.30% | 9.70% | 3.60% | Upgrade
|
| Earnings Yield | 1.91% | 3.41% | 3.27% | 2.23% | 1.99% | 0.27% | Upgrade
|
| FCF Yield | 2.09% | 4.34% | 4.23% | 3.55% | 5.39% | 2.50% | Upgrade
|
| Dividend Yield | 0.24% | 0.45% | - | - | - | - | Upgrade
|
| Payout Ratio | 26.49% | 10.35% | 12.31% | 7.24% | 8.77% | 68.07% | Upgrade
|
| Buyback Yield / Dilution | 0.03% | 0.08% | 0.09% | 0.12% | 0.11% | 0.09% | Upgrade
|
| Total Shareholder Return | 0.27% | 0.53% | 0.09% | 0.12% | 0.11% | 0.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.